Johan Neyts to Models, Molecular
This is a "connection" page, showing publications Johan Neyts has written about Models, Molecular.
Connection Strength
0.140
-
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
Score: 0.020
-
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 04 29; 184(9):2332-2347.e16.
Score: 0.020
-
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nat Chem Biol. 2021 02; 17(2):222-228.
Score: 0.019
-
Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors. J Med Chem. 2018 09 27; 61(18):8390-8401.
Score: 0.017
-
Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication. J Med Chem. 2018 09 27; 61(18):8402-8416.
Score: 0.017
-
Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds. ChemMedChem. 2018 07 18; 13(14):1371-1376.
Score: 0.016
-
A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication. J Med Chem. 2017 07 13; 60(13):5472-5492.
Score: 0.015
-
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases. J Med Chem. 2017 02 23; 60(4):1400-1416.
Score: 0.015